Search - tctmd.com

Displaying 181 - 200 of 403

Sort: Relevancy | Date

Presentation TCT 2017

Case Conclusion: How I Treated a Long Segment SFA CTO

Presenter: Ehrin J. Armstrong, Sahil A. Parikh, Beau Hawkins

October 30, 2017

Presentation TCT 2017

Case Introduction: A Long Segment SFA CTO

Presenter: Ehrin J. Armstrong, Sahil A. Parikh, Beau Hawkins

October 30, 2017

Presentation TCT 2017

Maintain Femoral Skills! Rationale and Essential Technique

Presenter: Prashant Kaul, Jennifer A. Tremmel, Curtiss T. Stinis

October 30, 2017

Presentation TCT 2017

Operator and Patient Radiation Exposure: Radial vs Femoral Approach

Presenter: Prashant Kaul, Jennifer A. Tremmel, Alessandro Sciahbasi

October 30, 2017

Presentation TCT 2017

Case Presentation: Management of a Major SFA Dissection

Presenter: Michael Guiry, Julie Logan, Herbert D. Aronow

October 30, 2017

Presentation TCT 2017

SFA Dissections: Implications and Management

Presenter: Michael Guiry, Julie Logan, William A. Gray

October 30, 2017

Presentation TCT 2017

Debate: How should SFA Disease be Treated? In most cases DCB (± BMS)

Presenter: D. Christopher Metzger

October 30, 2017

Presentation TCT 2017

Debate: How should SFA Disease be Treated? In most cases DES!

Presenter: Philip Green

October 30, 2017

Presentation TCT 2017

Case #2: How I Treat Femoral Vein Occlusions (With Discussion)

Presenter: Mahmood K. Razavi, Sanjiv Lakhanpal

October 30, 2017

Presentation TCT 2017

The PRELUDE Study: Prospective Study for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and/or Popliteal Arteries Using the Serranator® Device

Presenter: Tony Das, Thomas Zeller, William A. Gray

October 30, 2017

Presentation CDM 2017

Femoral CTO: A Stepwise Approach for Recanalization

Presenter: Lawrence A. Garcia

October 05, 2017

Presentation CDM 2017

Transitiong From a CAD to Peripheral Vascular Disease Practice

Presenter: Terry R. Bowers

October 05, 2017

Presentation VIVA 2017

Is Aspirin Really a Class I Medication in Peripheral Artery Disease?

Presenter: Ehrin J. Armstrong

September 19, 2017

Presentation VIVA 2017

Results from the IN.PACT SFA Randomized Trial

Presenter: Peter A. Schneider

September 15, 2017

Presentation VIVA 2017

Two-year Results from the IN.PACT Global Study

Presenter: Thomas Zeller

September 14, 2017

Presentation VIVA 2017

Paclitaxel-Eluting Stent Treatment for PAD: Insights from the Zilver PTX Post-Market Study in Japan

Presenter: Michael Dake

September 14, 2017

Presentation iASSESS 2017

Femoral Access and Related Complications

Presenter: Arnold Seto

August 30, 2017

Presentation CHIP Seattle 2017

Device Therapy for Cardiogenic Shock

Presenter: Jennifer A Tremmel

August 11, 2017

Presentation CHIP Seattle 2017

Complications: Managing Access Site Complications

Presenter: Colm Hanratty

August 11, 2017

Presentation TVT 2017

Inadequate Femoral Access All Roads Lead to Rome

Presenter: John K. Forrest, James M. McCabe, Adam B. Greenbaum

June 16, 2017

Advertisement

Case Conclusion: How I Treated a Long Segment SFA CTO

Case Introduction: A Long Segment SFA CTO

Maintain Femoral Skills! Rationale and Essential Technique

Operator and Patient Radiation Exposure: Radial vs Femoral Approach

Case Presentation: Management of a Major SFA Dissection

SFA Dissections: Implications and Management

Debate: How should SFA Disease be Treated? In most cases DCB (± BMS)

Debate: How should SFA Disease be Treated? In most cases DES!

Case #2: How I Treat Femoral Vein Occlusions (With Discussion)

The PRELUDE Study: Prospective Study for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and/or Popliteal Arteries Using the Serranator® Device

Femoral CTO: A Stepwise Approach for Recanalization

Transitiong From a CAD to Peripheral Vascular Disease Practice

Is Aspirin Really a Class I Medication in Peripheral Artery Disease?

Results from the IN.PACT SFA Randomized Trial

Two-year Results from the IN.PACT Global Study

Paclitaxel-Eluting Stent Treatment for PAD: Insights from the Zilver PTX Post-Market Study in Japan

Femoral Access and Related Complications

Device Therapy for Cardiogenic Shock

Complications: Managing Access Site Complications

Inadequate Femoral Access All Roads Lead to Rome

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content